Genscript Biotech Corporation
GNNSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $2,863 | -$351 | -$432 | -$496 |
| Dep. & Amort. | $62 | $74 | $64 | $48 |
| Deferred Tax | $0 | $0 | $13 | $12 |
| Stock-Based Comp. | $77 | $61 | $65 | $40 |
| Change in WC | $85 | -$151 | $170 | $122 |
| Other Non-Cash | -$3,011 | $80 | -$1 | $138 |
| Operating Cash Flow | $76 | -$287 | -$120 | -$137 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$147 | -$158 | -$204 | -$137 |
| Net Acquisitions | $0 | $0 | -$1 | -$4 |
| Inv. Purchases | -$3,365 | -$5,744 | -$410 | -$323 |
| Inv. Sales/Matur. | $2,569 | $5,660 | $188 | $244 |
| Other Inv. Act. | -$514 | -$116 | -$17 | $7 |
| Investing Cash Flow | -$1,456 | -$358 | -$443 | -$213 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $45 | $50 | $33 | -$49 |
| Stock Issued | $13 | $1,030 | $423 | $951 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $8 | -$9 | -$37 | -$0 |
| Financing Cash Flow | $67 | $1,068 | $419 | $902 |
| Forex Effect | -$0 | -$1 | -$13 | -$1 |
| Net Chg. in Cash | -$1,314 | $422 | -$157 | $552 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,446 | $1,024 | $1,181 | $629 |
| End Cash | $132 | $1,446 | $1,024 | $1,181 |
| Free Cash Flow | -$72 | -$445 | -$324 | -$274 |